openPR Logo
Press release

World Summit Expo on Vaccines & Immunology

01-28-2020 01:14 PM CET | Associations & Organizations

Press release from: Linkin science

Linkin Science, welcomes you all to the World Summit Expo on Vaccines & Immunology with the theme "New approaches to vaccine immunization and drug development" which will be hosted in Paris, France during July 27 - 29, 2020.
Vaccine development provides a measureable return in reducing the burden of disease and safeguarding human development. Today, more than ever, vaccine technology remains at the forefront to prevent and control infectious and non-infectious diseases in humans and animals. Vaccine Summit will cover a wide range of topics in this evolving field, including the latest advancements and applications of vaccine technologies, Therapeutic Vaccines, Vaccine Production, development of effective vaccine adjuvants, Malarial Vaccines, Veterinary vaccines, Infuenza Vaccines, Synthetic Genomics Based Vaccines and progress in DNA- and RNA-based vaccines. Immunology focuses on the human body's built-in defense system. In a healthy person, the immune system helps the body fight infection by rejecting foreign viruses and bacteria. When the immune system is defective, it can fail to protect the body, or even attack it. Diseases caused by disorders of the immune system may be caused by immunodeficiency, in which parts of the immune system fail to provide an adequate response, or autoimmunity, in which the immune system over responds, causing damage to the body of its host. Other immune disorders include hypersensitivity, in which the system responds inappropriately or too intensely to harmless compounds, as in asthma and allergies.

649 Mission St., 5th Floor, San Francisco, CA 94105
Email vaccinesummit@linkinscience.com

Linkin Science conferences are well crafted and designed by a team of skilled experts. Our conferences are vast expanded into Medical, life sciences, health care, Engineering and other social sciences. Each conference, summit or executive briefing is tailored to the sector, topic and audience need. Our event structure varies depending on issue and market requirements featuring Keynote presentations, Oral talks, Special sessions, Short courses, Poster presentations, Young research forum, Exhibitions, roundtables and variable formats

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release World Summit Expo on Vaccines & Immunology here

News-ID: 1910474 • Views:

More Releases for Vaccine

Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%. An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the